These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 11436958)

  • 21. Interaction of serotonin re-uptake inhibitors with perhexiline.
    Alderman CP; Hundertmark JD; Soetratma TW
    Aust N Z J Psychiatry; 1997 Aug; 31(4):601-3. PubMed ID: 9272272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents].
    Bailly D
    Presse Med; 2006 Sep; 35(9 Pt 2):1293-302. PubMed ID: 16969324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cutaneous adverse effects during selective serotonin reuptake inhibitors therapy: 2 cases].
    Richard MA; Fiszenson F; Jreissati M; Jean Pastor MJ; Grob JJ
    Ann Dermatol Venereol; 2001; 128(6-7):759-61. PubMed ID: 11460042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxetine-induced somnambulism.
    Kawashima T; Yamada S
    J Clin Psychiatry; 2003 Apr; 64(4):483. PubMed ID: 12716257
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
    Scholl HP; Kasper S; Danos P; Höflich G; Möller HJ
    Nervenarzt; 1994 Jul; 65(7):478-81. PubMed ID: 7800092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inability to cry during SRI treatment.
    Oleshansky MA; Labbate LA
    J Clin Psychiatry; 1996 Dec; 57(12):593. PubMed ID: 9010124
    [No Abstract]   [Full Text] [Related]  

  • 29. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of children with antidepressants: focus on selective serotonin reuptake inhibitors.
    Emslie GJ; Weinberg WA; Mayes TL
    Depress Anxiety; 1998; 8 Suppl 1():13-7. PubMed ID: 9809209
    [No Abstract]   [Full Text] [Related]  

  • 31. Care of depressed patients with anxiety symptoms.
    Nutt DJ
    J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of SSRI response.
    Salzman C
    Harv Rev Psychiatry; 1996; 4(4):215-7. PubMed ID: 9384996
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole Treatment for Obsessive Compulsive Disorder in 2 Young Subjects Who Could Not Tolerate Selective Serotonin Reuptake Inhibitors (SSRIs).
    Coskun M; Karayagmurlu A
    J Clin Psychopharmacol; 2020; 40(3):310-312. PubMed ID: 32332471
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C
    J Clin Psychiatry; 1999; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine.
    Brody AL; Saxena S; Fairbanks LA; Alborzian S; Demaree HA; Maidment KM; Baxter LR
    J Clin Psychiatry; 2000 May; 61(5):349-55. PubMed ID: 10847309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective serotonin reuptake inhibitors for children and adolescents.
    Kastelic EA; Labellarte MJ; Riddle MA
    Curr Psychiatry Rep; 2000 Apr; 2(2):117-23. PubMed ID: 11122943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.